NCT06876168

Brief Summary

This project is designed to have patients participate in a virtual environment with various tasks such as breathing exercises, games to help the brain, and techniques that promote relaxation while hospitalized in the Intensive Care Unit (ICU). The participation in research will last about 5 days and take about 15 to 45 minutes each day.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Jul 2025Sep 2026

First Submitted

Initial submission to the registry

February 24, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 14, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

July 2, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

February 24, 2025

Last Update Submit

September 29, 2025

Conditions

Keywords

virtual realityintensive care unitsepsisacute respiratory failure

Outcome Measures

Primary Outcomes (2)

  • System Usability Scale

    System Usability Scale - describing the ease of use of the procedure and device

    From enrollment to end of treatment (5 sessions); Day 1 through Day 5

  • Completion rate - feasibility

    Feasibility will be defined as the number of sessions completed as compared to the number of days after extubation (or BiPap removal, HFNC removal) and discharge from ICU/hospital.

    From enrollment to the end of treatment (5 sessions); Day 1 through Day 5

Secondary Outcomes (4)

  • MoCA

    Through study completion, typically occurring at hospital discharge or within 10 days of hospital discharge

  • Hospital Anxiety and Depression Survey (HADS)

    Through study completion, occurring at the time of hospital discharge, or at a 10, 30, or 60-day post-hospital discharge follow-up, conducted either at the ICU Recovery Clinic or by telephone.

  • IES-R

    Through study completion, occurring at the time of hospital discharge, or at a 10, 30, or 60-day post-hospital discharge follow-up, conducted either at the ICU Recovery Clinic or by telephone.

  • EQ5D

    Through study completion, typically occurring at hospital discharge or within 10 days of hospital discharge

Study Arms (1)

VR-PARTNER

Participants in ICU

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients in the intensive care unit at University of Kentucky with sepsis or acute respiratory failure.

You may qualify if:

  • Admitted to ICU at University of Kentucky for acute respiratory failure, sepsis or other

You may not qualify if:

  • Are less than 18 years of age
  • Have a pre-existing neurologic disorder
  • Have a pre-existing emotional or personality disorder
  • Have a history or active mental health disorder or disease
  • Experienced an acute neurologic event (e.g., stroke)
  • Are currently pregnant
  • Are a prisoner
  • Receiving hospice care
  • Have existing open wounds or pressure ulcers on head or neck

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40536, United States

RECRUITING

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Kirby P. Mayer, Ph.D.

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Louisa A Summers, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 24, 2025

First Posted

March 14, 2025

Study Start

July 2, 2025

Primary Completion (Estimated)

July 15, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

October 3, 2025

Record last verified: 2025-09

Locations